Bo Zhang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 2%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
- Genomics and Chromatin Dynamics
Papers in
-
- Cancer-related molecular mechanisms research 9
-
- Epigenetics and DNA Methylation 36
- RNA modifications and cancer 14
- Genomics and Chromatin Dynamics 12
- Cancer-related gene regulation 10
- Co-authors
- Ting WangDaofeng LiKeijiro SakuXiaoyun XingPaul GontarzCN CoonAndrew S. YooChristine J. Huh
- Journals
- PLoS ONE (9 papers)Circulation Journal (8 papers)Nature Communications (5 papers)Journal of Biological Chemistry (4 papers)Scientific Reports (4 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Bo Zhang
206 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 165
- Cancer Research 816
- Molecular Biology 3.2k
- Aging 53
- Rehabilitation 195
- Developmental Neuroscience 114
Countries citing papers authored by Bo Zhang
This map shows the geographic impact of Bo Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Zhang more than expected).
Fields of papers citing papers by Bo Zhang
This network shows the impact of papers produced by Bo Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Zhang. The network helps show where Bo Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 11 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 8 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 7 | |
| 10 | 2022 | 19 | |
| 11 | 2022 | 24 | |
| 12 | 2021 | 16 | |
| 13 | 2021 | 63 | |
| 14 | 2021 | 23 | |
| 15 | Metformin Increases the Chemosensitivity of Pancreatic Cancer Cells to Gemcitabine by Reversing EMT Through Regulation DNA Methylation of miR-663 | 2020 | 0 |
| 16 | 2020 | 34 | |
| 17 | 2017 | 81 | |
| 18 | 2016 | 1 | |
| 19 | 2015 | 33 | |
| 20 | 2011 | 5 |
About Bo Zhang
Bo Zhang is a scholar working on Cancer Research, Molecular Biology, Rheumatology, Cell Biology and Cardiology and Cardiovascular Medicine, having authored 223 papers that have together received 6.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (36 papers), Osteoarthritis Treatment and Mechanisms (16 papers), Atrial Fibrillation Management and Outcomes (15 papers), RNA modifications and cancer (14 papers), Genomics and Chromatin Dynamics (12 papers), Cancer-related gene regulation (10 papers), Cardiac Arrhythmias and Treatments (10 papers) and Cancer-related molecular mechanisms research (9 papers). The work is most often cited by research in Cancer Research (816 citations), Molecular Biology (3.2k citations), Aging (53 citations), Rehabilitation (195 citations) and Developmental Neuroscience (114 citations). Bo Zhang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Ting Wang, Daofeng Li, Keijiro Saku, Xiaoyun Xing, Paul Gontarz, CN Coon, Andrew S. Yoo, Christine J. Huh, Matheus B. Victor and Koichiro Kumagai. Their work appears in journals such as PLoS ONE, Circulation Journal, Nature Communications, Journal of Biological Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.